Prostate cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at a drug called MK-5684 for people with prostate cancer that has spread to another part of the body and has started to grow again.
It is open to people whose cancer started to grow again:
while having hormone treatment or
after having surgery to remove their testicles
Recruitment start: 17 September 2024
Recruitment end: 1 September 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Jones
Merck Sharp and Dohme LLC
Last reviewed: 18 May 2025
CRUK internal database number: 19945